CORONA Remedies Limited

NSE: CORONA

₹2,121.4

+0.09%EOD · 19 Aug

Market Cap

—

52W Range

₹2270 / ₹1337

Volume

62K

73.3% delivery

1Y Return

—

P/E Ratio

65.7

P/B Ratio

17.5

ROE

27.4%

Debt / Equity

22.07

Technical Indicators

185d data — partial · objective math, not advice

Returns

+0.1%

+0.4%

+23.0%

+35.6%

—

RSI (14)

52 Neutral

RS vs Nifty (3M)

+19.8pp

Moving Averages (price vs MA)

20-DMA

₹2103

above

50-DMA

₹2051

above

150-DMA

₹1777

above

200-DMA

—

From 52W High

-6.6%

From 52W Low

+58.7%

Support (20D)

₹2035

Resistance (20D)

₹2270

Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.

News & FilingsGoogle News + BSE

Stocks in news: IFCI, Tata Motors, General Insurance Corp, Corona Remedies, HFCL
The Economic Times· 18 Jun
Stocks to Watch Today: Rail Vikas Nigam, HFCL, Bosch Home Comfort, Lupin, Corona Remedies, Susan...
Moneycontrol.com· 18 Jun
Why did TCS shares crash over 8% today? Stock logs worst single-day fall since Covid-era rout
The Times of India· 3 Jun
Stocks to Watch Today: Sammaan Capital, Granules, IndiGo, Corona Remedies, Jubilant Ingrevia, Pace...
Moneycontrol.com· 1 Apr
CORONA Stock Price and Chart — NSE:CORONA
TradingView· 16 Jan
India’s Capital Markets Brace for Blockbuster NSE IPO
Global Finance Magazine· 13 Jul

News via Google News · Not verified by IPOpulse · Not investment advice

Community discussion(0)

No comments yet — be the first to share your view.